Arial Donnell
Vitiligo is a skin disease, which causes loss of color and white patches on the skin. The development of vitiligo occurs when the partial or complete loss of melanocytes produce irregular white spots (1). In the United States alone, the disease affects 1 in 200 people, and is much more noticeable among individuals with a darker complexion. As of now, no cure exists for vitiligo, but it is treated and managed by light therapy, creams, tropical medications, and skin transplants (2).
A new study has revealed skin transplant surgery is effective in treating vitiligo. Henry Ford Hospital was the first in America to try the surgery known as, melanocyte-keratinocyte transplant, or MKPT. The surgery places patients under anesthesia while taken skin cells from normally pigmented areas and replacing them to the damaged area of skin (2). Researches tested a group of men and women and checked their progress for up to six months. Drastic changes had taken place in the six-month span. More than half of the affected area was covered with their natural skin color.
The new study will have a great impact on people who are affected by the disease. Although the results did not show that the surgery was a hundred percent in replacing the white patches with ones natural skin tone, I think people who suffer from the disease will be satisfied for the amount that does. To me, this is a big confidence booster and will raise the self-esteem of the patient.
Tortora, Gerard J., and Bryan Derrickson. Principles of Anatomy and Physiology. Hoboken, NJ: John Wiley & Sons, 2010. Print.
Henry Ford Health System. “Skin transplant offers new hope to vitiligo patients.” ScienceDaily, 10 Mar. 2010. Web. 28 Feb. 2013.